サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1284875

ランセットの世界市場：種類別 (セーフティランセット、標準型ランセット)・用途別・ゲージサイズ別・年齢層別・エンドユーザー別・地域別の将来予測 (2028年まで)

Lancets Market by Type (Safety Lancets, Standard Lancets, Application, Gauze Size, Age Group, End Users, Region - Global Forecast to 2028
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 212 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ランセットの世界市場：種類別 (セーフティランセット、標準型ランセット)・用途別・ゲージサイズ別・年齢層別・エンドユーザー別・地域別の将来予測 (2028年まで)
出版日: 2023年05月29日
発行: MarketsandMarkets
ページ情報: 英文 212 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のランセットの市場規模は、2023年の23億米ドルから、2028年には36億米ドルに達し、予測期間中に9.7%のCAGRで成長すると予測されています。

ランセット市場の成長は、主に糖尿病の有病率の増加、慢性疾患の高い有病率、老年人口の増加によってもたらされます。しかし、ランセットに関連した針刺し傷害のリスク、ランセットの再利用、償還金削減や予算制約による価格圧力が、この市場の成長を制限しています。

"種類別では予測期間中に、セーフティランセット分野が最も高い市場シェアを占める"

セーフティランセットは、手動作動式と自動作動式/圧力作動式に細分化されます。プッシュボタンランセットとサイドボタンランセットは、老年人口の増加に伴い、最も高い成長が見込まれています。

"用途別では、グルコース検査が予測期間中に最も高いCAGRを占める"

用途別に見ると、2022年にはグルコース検査が市場を独占し、最も高い成長率を達成する見通しです。市場の成長を支える要因は、糖尿病の有病率の上昇と自己モニタリング装置の導入増加によるものです。

"地域別では、予測期間中は北米が最も高い市場シェアを占める"

地域別に見ると、北米が予測期間中に高い市場シェアを示すと予想されます。様々な慢性疾患の有病率の上昇に伴う病院や手術センターの増加によるもまた、ランセット市場の成長を後押ししています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • バリューチェーン分析
  • サプライチェーン分析
  • ポーターのファイブフォース分析
  • 主要な利害関係者と購入基準
  • 規制状況
  • 貿易分析
  • エコシステム分析
  • 特許分析
  • 主な会議とイベント (2023年～2024年)
  • 価格分析
  • 顧客のビジネスに影響を与える動向/混乱
  • 技術分析

第6章 ランセット市場：種類別

  • イントロダクション
  • セーフティランセット
    • 手動作動式ランセット
    • 自動作動式/圧力作動式ランセット
  • 標準型ランセット

第7章 ランセット市場：ゲージサイズ別

  • イントロダクション
  • 22G以下
  • 23G～33G
  • 33G超

第8章 ランセット市場：年齢層別

  • イントロダクション
  • 成人
  • 小児

第9章 ランセット市場：用途別

  • イントロダクション
  • グルコース検査
  • ヘモグロビン検査
  • 凝固検査
  • コレステロール検査
  • アレルギー検査
  • 新生児スクリーニング
  • その他の用途

第10章 ランセット市場：エンドユーザー別

  • イントロダクション
  • 病院・診療所・外来手術センター
  • 在宅医療
  • その他のエンドユーザー

第11章 地域別のランセット市場

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • その他のアジア太平洋
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第12章 競合情勢

  • 概要
  • 上位企業の収益シェア分析
  • 市場シェア分析
  • 競合リーダーシップマッピング
  • 中小企業/スタートアップ向け企業評価クアドラント
  • 競合ベンチマーキング
  • 企業フットプリント分析
  • 競合シナリオ

第13章 企業プロファイル

  • 主要企業
    • BECTON, DICKINSON AND COMPANY
    • F. HOFFMANN-LA ROCHE LTD.
    • YPSOMED
    • B. BRAUN SE
    • TERUMO CORPORATION
    • GREINER BIO-ONE INTERNATIONAL GMBH
    • ABBOTT LABORATORIES
    • OWEN MUMFORD
    • HTL-STREFA S.A.
    • ARKRAY, INC.
    • SARSTEDT AG & CO. KG
    • STERILANCE MEDICAL (SUZHOU) INC.
    • MEDLINE INDUSTRIES
    • AGAMATRIX, INC.
    • ACON LABORATORIES, INC.
    • SANLI MEDICAL & HEALTH SERVICE
    • ALLISON MEDICAL, INC.
    • GLUCORX LIMITED
  • その他の企業
    • FL MEDICAL S.R.L
    • MHC MEDICAL PRODUCTS, LLC
    • NEOMEDIC
    • CML BIOTECH LTD.
    • DISERA TIBBI MALZEME LOJISTIK SANAYI VE TICARET A.S.
    • A. MENARINI DIAGNOSTICS S.R.L

第14章 付録

目次
Product Code: MD 7166

The lancets market is projected to reach USD 3.6 Billion by 2028 from USD 2.3 Billion in 2023, at a CAGR of 9.7% during the forecast period. Growth in the lancets market is mainly driven by the growing prevalence of diabetes, the high prevalence of chronic diseases and the rising geriatric population. However, the risk of lancet-related needlestick injuries, the reuse of lancets, and Pricing pressure owing to reimbursement cuts and budget constraints are restricting the growth of this market.

"The Safety lancet segment accounted for the highest market share in the lancets systems market, by type, during the forecast period"

Based on the type of segment, the lancets system market is categorized into standard lancets and safety lancets. Safety lancet are sub categorized into Manually Activated and Automatically activated/Pressure activated. Push Button Lancets and Side Button Lancets Manually Activated are expected to the highest growth in the market which attributed to the growing geriatric population.

"Glucose Testing application accounted for the highest CAGR during the forecast period."

Based on type, the application market is segmented into Glucose Testing, Hemoglobin Testing, Coagulation Testing, Cholesterol Testingm, Allergy Testing, Neonatal Screening and Other Applications. In 2022, the Glucose Testing dominated the market and the lancets market to observe the highest growth rate. Factors supporting the growth of the market is due to the growing prevalence of diabetes and increasing adoption of self-monitoring devices.

"The North America segment accounted for the highest market share in the lancets systems market, by region, during the forecast period"

Based on the region, the global lancets market is categorized into North America, Europe, Asia Pacific, and Rest of the world. North America is expected to witness high market share during the forecast period. Rising prevalence of various chronic diseases which is attributed to the demand of rising number of hospitals and surgical centers are also supporting the growth of the lancets market.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (32%), Tier 2 (46%), and Tier 3 (22%)
  • By Designation: C-level (40%), Director-level (26%), and Others (32%)
  • By Region: North America (35%), Asia- Pacific (21%), Europe (30%), Latin America (14%) and Middle East & Africa(3%)

Prominent companies include Becton, Dickinson and Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), B. Braun SE (Germany), Abbott Laboratories (US), Greiner Bio-One International GmbH (Austria), Ypsomed (Switzerland), Terumo Corporation (Japan), Owen Mumford (UK), HTL-STREFA S.A. (Poland), ARKRAY, Inc. (Japan), SARSTEDT AG & Co. KG (Germany), SteriLance Medical (China), Medline Industries (US), AgaMatrix Holdings LLC (US), ACON Laboratories, Inc. (US), SANLI Medical & Health Service (China), Allison Medical Inc. (US), GlucoRx Limited (UK), FL Medical s.r.l. (Italy), A. Menarini Diagnostics s.r.l (Italy), CML Biotech (India), Neomedic (Spain), MHC Medical Products (US), and Disera TIbbi Malzeme Lojistik Sanayi ve Ticaret A.S. (Turkey).

Research Coverage

This research report categorizes the lancets market by type (Safety and Standard lancets), by application (Glucose Testing, Hemoglobin Testing, Coagulation Testing, Cholesterol Testing, Allergy Testing, Neonatal Screening and Other Applications), by end user (Hospitals, Clinics and Ambulatory Surgery Centers, Homecare settings and Other end users (Diagnostic centers, Nursing Homes, Long Term Acute Care Centers, Emergency Medical Service Providers, and Academic Research Institutes), and region (North America, Europe, Asia Pacific and Rest of world). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the lancets market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the lancets market. Competitive analysis of upcoming startups in the Lancets market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Lancets market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Growing prevalence of diabetes and increasing adoption of self-monitoring devices, Rising prevalence of various chronic diseases, Increasing demand for painless lancets, Growing geriatric population, Rising number of hospitals and surgical centers), restraints (Increasing incidence of lancet-related needlestick injuries and infections and Pricing pressure owing to reimbursement cuts and budget constraints) opportunities (Increasing incidence of lancet-related needlestick injuries and infections and Pricing pressure owing to reimbursement cuts and budget constraints), and challenges (Reuse of lancets) influencing the growth of the lancets market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Lancets market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the lancets market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the Lancets market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Becton, Dickinson and Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), B. Braun SE (Germany), Abbott Laboratories (US), and Greiner Bio-One International GmbH (Austria) and Terumo Corporation (Japan) among others in the lancets market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 LANCETS MARKET SEGMENTATION
    • 1.3.2 GEOGRAPHIC SCOPE
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
  • 1.6 MARKET STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primary interviews
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND- SIDE PARTICIPANTS
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION
    • TABLE 1 LANCETS MARKET: COUNTRY-LEVEL ANALYSIS (1/2)
    • FIGURE 7 LANCETS MARKET: COUNTRY-LEVEL ANALYSIS (2/2)
    • 2.2.1 GROWTH FORECAST
    • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 9 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 ASSUMPTIONS
  • 2.6 MARKET INDICATORS AND THEIR IMPACT
  • 2.7 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT
  • 2.8 IMPACT OF RECESSION: LANCETS MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 11 LANCETS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 LANCETS MARKET, BY GAUGE SIZE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 LANCETS MARKET, BY AGE GROUP, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 LANCETS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 LANCETS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 GEOGRAPHICAL SNAPSHOT OF LANCETS MARKET

4 PREMIUM INSIGHTS

  • 4.1 LANCETS MARKET OVERVIEW
    • FIGURE 17 INCREASING INCIDENCE OF DIABETES TO DRIVE MARKET
  • 4.2 NORTH AMERICA: LANCETS MARKET, BY TYPE AND COUNTRY (2022)
    • FIGURE 18 SAFETY LANCETS HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
  • 4.3 LANCETS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 20 LANCETS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing prevalence of diabetes and increasing adoption of self-monitoring devices
    • FIGURE 21 INCIDENCE OF DIABETES, 2021 VS. 2045 (MILLION)
      • 5.2.1.2 Rising prevalence of various chronic diseases
    • FIGURE 22 US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1995-2030 (MILLION)
      • 5.2.1.3 Increasing demand for painless lancets
      • 5.2.1.4 Growing geriatric population
    • TABLE 3 GLOBAL GERIATRIC POPULATION, BY REGION, 2019 VS. 2030
      • 5.2.1.5 Rising number of hospitals and surgical centers
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Increasing incidence of lancet-related needlestick injuries and infections
      • 5.2.2.2 Pricing pressure owing to reimbursement cuts and budget constraints
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 High growth prospects in emerging countries
      • 5.2.3.2 Increasing awareness of novel technologies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Reuse of lancets
  • 5.3 VALUE CHAIN ANALYSIS
    • FIGURE 23 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • 5.4 SUPPLY CHAIN ANALYSIS
    • FIGURE 24 DIRECT DISTRIBUTION-PREFERRED STRATEGY FOR PROMINENT COMPANIES
  • 5.5 PORTER'S FIVE FORCES ANALYSIS
    • 5.5.1 THREAT OF NEW ENTRANTS
    • 5.5.2 INTENSITY OF COMPETITIVE RIVALRY
    • 5.5.3 BARGAINING POWER OF BUYERS
    • 5.5.4 BARGAINING POWER OF SUPPLIERS
    • 5.5.5 THREAT OF SUBSTITUTES
  • 5.6 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS
    • TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP END USERS (%)
    • 5.6.2 BUYING CRITERIA
    • FIGURE 26 KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS
    • TABLE 5 KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS
  • 5.7 REGULATORY LANDSCAPE
    • 5.7.1 NORTH AMERICA
      • 5.7.1.1 US
      • 5.7.1.2 Canada
    • TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 5.7.2 EUROPE
    • 5.7.3 ASIA PACIFIC
      • 5.7.3.1 Japan
    • TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.7.3.2 China
    • TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.7.3.3 India
  • 5.8 TRADE ANALYSIS
    • TABLE 9 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 10 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018-2022 (USD MILLION)
  • 5.9 ECOSYSTEM ANALYSIS
    • TABLE 11 ROLE IN ECOSYSTEM
    • FIGURE 27 KEY PLAYERS OPERATING IN LANCETS MARKET
  • 5.10 PATENT ANALYSIS
  • 5.11 KEY CONFERENCES AND EVENTS IN 2023-2024
    • TABLE 12 LIST OF CONFERENCES AND EVENTS
  • 5.12 PRICING ANALYSIS
    • 5.12.1 AVERAGE SELLING PRICE OF KEY PRODUCTS
    • TABLE 13 PRICE RANGE OF KEY PRODUCTS IN THE LANCETS MARKET (USD)
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.14 TECHNOLOGY ANALYSIS

6 LANCETS MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • FIGURE 28 LANCETS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • TABLE 14 LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 6.2 SAFETY LANCETS
    • TABLE 15 SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 16 SAFETY LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.1 MANUALLY ACTIVATED LANCETS
    • TABLE 17 MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 18 MANUALLY ACTIVATED LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 6.2.1.1 Side-button lancets
        • 6.2.1.1.1 Anti-reuse measures to increase popularity among end users
    • TABLE 19 SIDE-BUTTON LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 6.2.1.2 Push-button lancets
        • 6.2.1.2.1 Ease of use and simplicity to drive demand
    • TABLE 20 PUSH-BUTTON LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.2 AUTOMATICALLY ACTIVATED/PRESSURE-ACTIVATED LANCETS
      • 6.2.2.1 Available in number of gauge sizes and penetration depths
    • TABLE 21 AUTOMATICALLY ACTIVATED/PRESSURE-ACTIVATED LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3 STANDARD LANCETS
    • 6.3.1 INCREASING PREVALENCE OF DIABETES TO DRIVE ADOPTION
    • TABLE 22 STANDARD LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)

7 LANCETS MARKET, BY GAUGE SIZE

  • 7.1 INTRODUCTION
    • FIGURE 29 LANCETS MARKET, BY GAUGE SIZE, 2023 VS. 2028 (USD MILLION)
    • TABLE 23 LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
  • 7.2 22G AND BELOW
    • 7.2.1 BENEFICIAL FOR MEDICAL TESTS THAT REQUIRE LARGER SAMPLE SIZE
    • TABLE 24 22G AND BELOW LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.3 23G-33G
    • 7.3.1 WIDE AVAILABILITY OF 23G-33G LANCETS TO AID MARKET GROWTH
    • TABLE 25 23G-33G LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.4 ABOVE 33G
    • 7.4.1 LESS PAIN AND DISCOMFORT TO DRIVE ADOPTION
    • TABLE 26 ABOVE 33G LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)

8 LANCETS MARKET, BY AGE GROUP

  • 8.1 INTRODUCTION
    • FIGURE 30 LANCETS MARKET, BY AGE GROUP, 2023 VS. 2028 (USD MILLION)
    • TABLE 27 LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
  • 8.2 ADULT
    • 8.2.1 LARGEST AND FASTEST-GROWING SEGMENT
    • TABLE 28 ADULT LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 PEDIATRIC
    • 8.3.1 INCREASING PREVALENCE OF TYPE 1 DIABETES IN PEDIATRIC PATIENTS TO DRIVE MARKET
    • TABLE 29 PEDIATRIC LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)

9 LANCETS MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • FIGURE 31 LANCETS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • TABLE 30 LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 9.2 GLUCOSE TESTING
    • 9.2.1 RISING PREVALENCE OF DIABETES TO DRIVE MARKET
    • TABLE 31 LANCETS MARKET FOR GLUCOSE TESTING, BY REGION, 2021-2028 (USD MILLION)
  • 9.3 HEMOGLOBIN TESTING
    • 9.3.1 HIGH PREVALENCE OF ANEMIA TO DRIVE DEMAND
    • TABLE 32 LANCETS MARKET FOR HEMOGLOBIN TESTING, BY REGION, 2021-2028 (USD MILLION)
  • 9.4 COAGULATION TESTING
    • 9.4.1 RISING PREVALENCE OF LIVER DISEASES, THROMBOPHILIA, AND HEMOPHILIA TO DRIVE MARKET
    • TABLE 33 LANCETS MARKET FOR COAGULATION TESTING, BY REGION, 2021-2028 (USD MILLION)
  • 9.5 CHOLESTEROL TESTING
    • 9.5.1 RISING DEMAND FOR CHOLESTEROL HOME TEST KITS TO SUPPORT MARKET GROWTH
    • TABLE 34 LANCETS MARKET FOR CHOLESTEROL TESTING, BY REGION, 2021-2028 (USD MILLION)
  • 9.6 ALLERGY TESTING
    • 9.6.1 HIGH DEMAND FOR SPT TO PROPEL MARKET
    • TABLE 35 LANCETS MARKET FOR ALLERGY TESTING, BY REGION, 2021-2028 (USD MILLION)
  • 9.7 NEONATAL SCREENING
    • 9.7.1 GROWING NEED FOR DRY BLOOD SPOT TESTS TO DRIVE MARKET
    • TABLE 36 LANCETS MARKET FOR NEONATAL SCREENING, BY REGION, 2021-2028 (USD MILLION)
  • 9.8 OTHER APPLICATIONS
    • TABLE 37 LANCETS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)

10 LANCETS MARKET, BY END USER

  • 10.1 INTRODUCTION
    • FIGURE 32 LANCETS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • TABLE 38 LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.2 HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS
    • 10.2.1 INCREASING INCIDENCE OF CHRONIC DISEASES TO DRIVE ADOPTION OF LANCETS
    • TABLE 39 LANCETS MARKET FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • 10.3 HOME CARE SETTINGS
    • 10.3.1 TECHNOLOGICAL ADVANCEMENTS IN SELF/HOME CARE GLUCOSE MONITORING SYSTEMS TO DRIVE MARKET
    • TABLE 40 LANCETS MARKET FOR HOME CARE SETTINGS, BY REGION, 2021-2028 (USD MILLION)
  • 10.4 OTHER END USERS
    • TABLE 41 LANCETS MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)

11 LANCETS MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 42 LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 11.2 NORTH AMERICA
    • 11.2.1 NORTH AMERICA: IMPACT OF RECESSION
    • FIGURE 33 NORTH AMERICA: LANCETS MARKET SNAPSHOT
    • TABLE 43 NORTH AMERICA: LANCETS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 NORTH AMERICA: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 45 NORTH AMERICA: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 46 NORTH AMERICA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 47 NORTH AMERICA: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 48 NORTH AMERICA: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 49 NORTH AMERICA: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 50 NORTH AMERICA: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.2.2 US
      • 11.2.2.1 Increasing incidence and prevalence of lifestyle diseases to drive market
    • TABLE 51 US: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 52 US: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 53 US: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 54 US: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 55 US: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 56 US: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 57 US: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.2.3 CANADA
      • 11.2.3.1 Rising incidence of allergies to drive market
    • TABLE 58 CANADA: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 59 CANADA: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 60 CANADA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 61 CANADA: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 62 CANADA: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 63 CANADA: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 64 CANADA: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3 EUROPE
    • 11.3.1 EUROPE: IMPACT OF RECESSION
    • TABLE 65 EUROPE: LANCETS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 EUROPE: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 67 EUROPE: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 68 EUROPE: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 69 EUROPE: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 70 EUROPE: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 71 EUROPE: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 72 EUROPE: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.2 GERMANY
      • 11.3.2.1 Germany to dominate European lancets market
    • TABLE 73 GERMANY: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 74 GERMANY: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 75 GERMANY: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 76 GERMANY: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 77 GERMANY: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 78 GERMANY: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 79 GERMANY: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 Growing public-private collaborations for product development to support market growth
    • TABLE 80 FRANCE: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 81 FRANCE: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 82 FRANCE: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 83 FRANCE: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 84 FRANCE: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 85 FRANCE: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 86 FRANCE: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.4 UK
      • 11.3.4.1 Increasing prevalence of lifestyle diseases to drive market
    • TABLE 87 UK: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 88 UK: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 89 UK: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 90 UK LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 91 UK: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 92 UK: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 93 UK: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.5 ITALY
      • 11.3.5.1 Slower growth in healthcare sector to restrain market growth
    • TABLE 94 ITALY: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 95 ITALY: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 96 ITALY: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 97 ITALY: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 98 ITALY: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 99 ITALY: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 100 ITALY: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.6 SPAIN
      • 11.3.6.1 Increasing funding for research to boost market growth
    • TABLE 101 SPAIN: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 102 SPAIN: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 103 SPAIN: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 104 SPAIN: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 105 SPAIN: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 106 SPAIN: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 107 SPAIN: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.7 REST OF EUROPE
    • TABLE 108 REST OF EUROPE: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 109 REST OF EUROPE: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 110 REST OF EUROPE: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 111 REST OF EUROPE: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 112 REST OF EUROPE: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 113 REST OF EUROPE: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 114 REST OF EUROPE: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • 11.4.1 ASIA PACIFIC: IMPACT OF RECESSION
    • FIGURE 34 ASIA PACIFIC: LANCETS MARKET SNAPSHOT
    • TABLE 115 ASIA PACIFIC: LANCETS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 116 ASIA PACIFIC: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 ASIA PACIFIC: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 121 ASIA PACIFIC: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 122 ASIA PACIFIC: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.2 JAPAN
      • 11.4.2.1 Well-established healthcare system to support market growth
    • TABLE 123 JAPAN: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 124 JAPAN: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 125 JAPAN: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 126 JAPAN: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 127 JAPAN: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 128 JAPAN: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 129 JAPAN: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.3 CHINA
      • 11.4.3.1 Fastest-growing market for lancets
    • TABLE 130 CHINA: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 131 CHINA: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 132 CHINA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 133 CHINA: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 134 CHINA: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 135 CHINA: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 136 CHINA: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.4 INDIA
      • 11.4.4.1 High burden of chronic diseases to support market growth
    • TABLE 137 INDIA: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 138 INDIA: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 139 INDIA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 140 INDIA: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 141 INDIA: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 142 INDIA: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 143 INDIA: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Increasing government initiatives to aid market growth
    • TABLE 144 SOUTH KOREA: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 145 SOUTH KOREA: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 146 SOUTH KOREA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 147 SOUTH KOREA: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 148 SOUTH KOREA: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 149 SOUTH KOREA: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 150 SOUTH KOREA: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.6 REST OF ASIA PACIFIC
    • TABLE 151 REST OF ASIA PACIFIC: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 152 REST OF ASIA PACIFIC: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 153 REST OF ASIA PACIFIC: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 154 REST OF ASIA PACIFIC: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 155 REST OF ASIA PACIFIC: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 156 REST OF ASIA PACIFIC: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 157 REST OF ASIA PACIFIC: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.5 REST OF THE WORLD
    • TABLE 158 REST OF THE WORLD: LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 159 REST OF THE WORLD: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 160 REST OF THE WORLD: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 161 REST OF THE WORLD: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 162 REST OF THE WORLD: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 163 REST OF THE WORLD: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 164 REST OF THE WORLD: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 165 REST OF THE WORLD: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.5.1 LATIN AMERICA
      • 11.5.1.1 Rising prevalence of diabetes and cancer to support market growth
      • 11.5.1.2 Latin America: Impact of recession
    • TABLE 166 LATIN AMERICA: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 167 LATIN AMERICA: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 168 LATIN AMERICA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 169 LATIN AMERICA: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 170 LATIN AMERICA: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 171 LATIN AMERICA: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 172 LATIN AMERICA: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.5.2 MIDDLE EAST AND AFRICA
      • 11.5.2.1 Rising geriatric population and increasing prevalence of chronic diseases to drive market
      • 11.5.2.2 Middle East & Africa: Impact of recession
    • TABLE 173 MIDDLE EAST AND AFRICA: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 174 MIDDLE EAST AND AFRICA: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 175 MIDDLE EAST AND AFRICA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 176 MIDDLE EAST AND AFRICA: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 177 MIDDLE EAST AND AFRICA: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 178 MIDDLE EAST AND AFRICA: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 179 MIDDLE EAST AND AFRICA: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
    • TABLE 180 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LANCETS MARKET
  • 12.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 35 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN LANCETS MARKET
  • 12.3 MARKET SHARE ANALYSIS
    • TABLE 181 LANCETS MARKET: DEGREE OF COMPETITION
  • 12.4 COMPETITIVE LEADERSHIP MAPPING
    • 12.4.1 STARS
    • 12.4.2 EMERGING LEADERS
    • 12.4.3 PERVASIVE PLAYERS
    • 12.4.4 PARTICIPANTS
    • FIGURE 36 LANCETS MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2022
  • 12.5 COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS
    • 12.5.1 PROGRESSIVE COMPANIES
    • 12.5.2 STARTING BLOCKS
    • 12.5.3 RESPONSIVE COMPANIES
    • 12.5.4 DYNAMIC COMPANIES
    • FIGURE 37 LANCETS MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS, 2022
  • 12.6 COMPETITIVE BENCHMARKING
    • TABLE 182 LANCETS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • 12.7 COMPANY FOOTPRINT ANALYSIS
    • TABLE 183 FOOTPRINT ANALYSIS OF COMPANIES
    • TABLE 184 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES
    • TABLE 185 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES
  • 12.8 COMPETITIVE SCENARIO
    • 12.8.1 PRODUCT LAUNCHES
    • TABLE 186 KEY PRODUCT LAUNCHES, JANUARY 2020-MAY 2023
    • 12.8.2 DEALS
    • TABLE 187 KEY DEALS, JANUARY 2020-MAY 2023
    • 12.8.3 OTHER DEVELOPMENTS
    • TABLE 188 OTHER KEY DEVELOPMENTS, JANUARY 2020-MAY 2023

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
  • (Business overview, Products offered, Recent Developments, MNM view)**
    • 13.1.1 BECTON, DICKINSON AND COMPANY
    • TABLE 189 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
    • 13.1.2 F. HOFFMANN-LA ROCHE LTD.
    • TABLE 190 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
    • FIGURE 39 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
    • 13.1.3 YPSOMED
    • TABLE 191 YPSOMED: BUSINESS OVERVIEW
    • FIGURE 40 YPSOMED: COMPANY SNAPSHOT (2022)
    • 13.1.4 B. BRAUN SE
    • TABLE 192 B. BRAUN SE: BUSINESS OVERVIEW
    • FIGURE 41 B. BRAUN SE: COMPANY SNAPSHOT (2022)
    • 13.1.5 TERUMO CORPORATION
    • TABLE 193 TERUMO CORPORATION: BUSINESS OVERVIEW
    • FIGURE 42 TERUMO CORPORATION: COMPANY SNAPSHOT (2022)
    • 13.1.6 GREINER BIO-ONE INTERNATIONAL GMBH
    • TABLE 194 GREINER BIO-ONE INTERNATIONAL GMBH: BUSINESS OVERVIEW
    • FIGURE 43 GREINER BIO-ONE INTERNATIONAL GMBH: COMPANY SNAPSHOT (2021)
    • 13.1.7 ABBOTT LABORATORIES
    • TABLE 195 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 44 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
    • 13.1.8 OWEN MUMFORD
    • TABLE 196 OWEN MUMFORD: BUSINESS OVERVIEW
    • 13.1.9 HTL-STREFA S.A.
    • TABLE 197 HTL-STREFA S.A.: BUSINESS OVERVIEW
    • 13.1.10 ARKRAY, INC.
    • TABLE 198 ARKRAY, INC.: BUSINESS OVERVIEW
    • 13.1.11 SARSTEDT AG & CO. KG
    • TABLE 199 SARSTEDT AG & CO. KG: BUSINESS OVERVIEW
    • 13.1.12 STERILANCE MEDICAL (SUZHOU) INC.
    • TABLE 200 STERILANCE MEDICAL (SUZHOU): BUSINESS OVERVIEW
    • 13.1.13 MEDLINE INDUSTRIES
    • TABLE 201 MEDLINE INDUSTRIES: BUSINESS OVERVIEW
    • 13.1.14 AGAMATRIX, INC.
    • TABLE 202 AGAMATRIX, INC.: BUSINESS OVERVIEW
    • 13.1.15 ACON LABORATORIES, INC.
    • TABLE 203 ACON LABORATORIES, INC.: BUSINESS OVERVIEW
    • 13.1.16 SANLI MEDICAL & HEALTH SERVICE
    • TABLE 204 SANLI MEDICAL & HEALTH SERVICE: BUSINESS OVERVIEW
    • 13.1.17 ALLISON MEDICAL, INC.
    • TABLE 205 ALLISON MEDICAL, INC.: BUSINESS OVERVIEW
    • 13.1.18 GLUCORX LIMITED
    • TABLE 206 GLUCORX LIMITED: BUSINESS OVERVIEW
  • *Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
  • 13.2 OTHER PLAYERS
    • 13.2.1 FL MEDICAL S.R.L
    • 13.2.2 MHC MEDICAL PRODUCTS, LLC
    • 13.2.3 NEOMEDIC
    • 13.2.4 CML BIOTECH LTD.
    • 13.2.5 DISERA TIBBI MALZEME LOJISTIK SANAYI VE TICARET A.S.
    • 13.2.6 A. MENARINI DIAGNOSTICS S.R.L

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS